P L C M van Riel - JoVE Visualize

Showing results (41-50 of 73) with videos related to

Pageof 8

Sort By:

Annals of the Rheumatic Diseases|July 17, 2004

Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritisA W T van Lieshout, P Barrera, R L Smeets, et al.

Patient Education and Counseling|January 12, 2008

Tailored cognitive-behavioral therapy for fibromyalgia: two case studiesS van Koulil, W van Lankveld, F W Kraaimaat, et al.

Scandinavian Journal of Rheumatology|October 28, 2010

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritisB J F van den Bemt, A A den Broeder, F H J van den Hoogen, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|September 27, 2007

Generalized and symptom-specific sensitization of chronic itch and painA I M van Laarhoven, F W Kraaimaat, O H Wilder-Smith, et al.

Arthritis Care & Research|February 26, 2013

Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohortM Vermeer, H H Kuper, H J Bernelot Moens, et al.

Annals of the Rheumatic Diseases|September 13, 2011

Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.

Scandinavian Journal of Rheumatology|July 2, 2004

Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexateR Rau, S Simianer, P L C M van Riel, et al.

Rheumatology (Oxford, England)|April 19, 2002

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritisP Barrera, A van der Maas, A E van Ede, et al.

Arthritis Care & Research|May 28, 2010

Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practiceM Blom, W Kievit, H H Kuper, et al.

Annals of the Rheumatic Diseases|February 5, 2008

Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration studyB J F van den Bemt, A A den Broeder, G F Snijders, et al.

Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:

Pageof 8

Annals of the Rheumatic Diseases|July 17, 2004

Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritisA W T van Lieshout, P Barrera, R L Smeets, et al.

Patient Education and Counseling|January 12, 2008

Tailored cognitive-behavioral therapy for fibromyalgia: two case studiesS van Koulil, W van Lankveld, F W Kraaimaat, et al.

Scandinavian Journal of Rheumatology|October 28, 2010

Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritisB J F van den Bemt, A A den Broeder, F H J van den Hoogen, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV|September 27, 2007

Generalized and symptom-specific sensitization of chronic itch and painA I M van Laarhoven, F W Kraaimaat, O H Wilder-Smith, et al.

Arthritis Care & Research|February 26, 2013

Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohortM Vermeer, H H Kuper, H J Bernelot Moens, et al.

Annals of the Rheumatic Diseases|September 13, 2011

Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.

Scandinavian Journal of Rheumatology|July 2, 2004

Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexateR Rau, S Simianer, P L C M van Riel, et al.

Rheumatology (Oxford, England)|April 19, 2002

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritisP Barrera, A van der Maas, A E van Ede, et al.

Arthritis Care & Research|May 28, 2010

Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practiceM Blom, W Kievit, H H Kuper, et al.

Annals of the Rheumatic Diseases|February 5, 2008

Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration studyB J F van den Bemt, A A den Broeder, G F Snijders, et al.

Pageof 8